Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Byun Website

Jung Shin Byun, Ph.D.

Selected Publications

1)  Byun JS, Gardner K.
C-Terminal Binding Protein: A Molecular Link between Metabolic Imbalance and Epigenetic Regulation in Breast Cancer.
Int J Cell Biol. 2013: 647975, 2013.
2)  Di LJ, Byun JS, Wong MM, Wakano C, Taylor T, Bilke S, Baek S, Hunter K, Yang H, Lee M, Zvosec C, Khramtsova G, Cheng F, Perou CM, Miller CR, Raab R, Olopade OI, Gardner K.
Genome-wide profiles of CtBP link metabolism with genome stability and epithelial reprogramming in breast cancer.
Nat Commun. 4: 1449, 2013.
3)  Byun JS, Gardner K.
Wounds that will not heal: pervasive cellular reprogramming in cancer.
Am. J. Pathol. 182: 1055-64, 2013.
4)  Byun JS, Fufa TD, Wakano C, Fernandez A, Haggerty CM, Sung MH, Gardner K.
ELL facilitates RNA polymerase II pause site entry and release.
Nat Commun. 3: 633, 2012.
5)  Wakano C, Byun JS, Di LJ, Gardner K.
The dual lives of bidirectional promoters.
Biochim. Biophys. Acta. 1819: 688-93, 2012.
6)  Li X, Li L, Pandey R, Byun JS, Gardner K, Qin Z, Dou Y.
The histone acetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptional network.
Cell Stem Cell. 11: 163-78, 2012.
7)  De Siervi A, De Luca P, Byun JS, Di LJ, Fufa T, Haggerty CM, Vazquez E, Moiola C, Longo DL, Gardner K.
Transcriptional autoregulation by BRCA1.
Cancer Res. 70: 532-42, 2010.
8)  Byun JS, Wong MM, Cui W, Idelman G, Li Q, De Siervi A, Bilke S, Haggerty CM, Player A, Wang YH, Thirman MJ, Kaberlein JJ, Petrovas C, Koup RA, Longo D, Ozato K, Gardner K.
Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.
Proc. Natl. Acad. Sci. U.S.A. 106: 19286-91, 2009.
9)  Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG, Figg WD, Quintero J, Haggerty CM, Li QQ, De Siervi A, Gardner K.
Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.
Mol. Pharmacol. 74: 872-83, 2008.
Click Here to View Collapsed Bibliography.

This page was last updated on 7/28/2013.